Related Guides
Continue your research with these related independent reviews.
Cheapest Compounded Tirzepatide 2026: Verified Provider Price Comparison
Compounded tirzepatide ranges from $167–$299/month without insurance — compared to $1,086+/month for branded Zepbound. Here are the verified 2026 prices from active telehealth providers, ranked by monthly cost.
| Provider | Monthly Price | Plan Type | Affiliate |
|---|---|---|---|
| TMatesLowest | ~$167/mo | 12-month commitment | See Pricing → |
| MEDVi | $179–$299/mo | Monthly / tiered | See Pricing → |
| Eden Health | $229–$299/mo | Includes metabolic panel | See Pricing → |
| Ivim Health | Verify directly | Microdosing specialist | See Pricing → |
| Zepbound (branded) | ~$1,086+/mo | Eli Lilly direct | Not compounded |
Compounded prices verified May 2026. Zepbound price is without insurance at retail. See our full cheapest tirzepatide guide for all 3 cost paths including insurance.
What Drives Price Differences Between Providers?
Commitment plan vs month-to-month
TMates's $167/month price requires a 12-month commitment. Month-to-month plans typically run $200–$299. If you're committed to a full year, the commitment plan saves significantly.
Clinical services included
Eden Health's higher price includes comprehensive metabolic bloodwork at intake. Providers with less included clinical support charge less.
Consultation fees
Some providers charge $50–$150 for the initial consultation separately. Others include it. Always ask before enrolling.
Dose/quantity included
What does the monthly price include — just the medication, or a titration progression? Confirm how many doses are included and how dose adjustments are handled.
Detailed Provider Options
~$167/month (12-mo tirzepatide plan)
Compounded tirzepatide. Best per-month price on a commitment plan. Highest EPC on Katalys ($16.09, 6.43% conversion rate). Strong patient support infrastructure.
- Best monthly price on commitment plan
- Katalys-verified high conversion
$179–$299/month
Verified pricing, strong brand recognition (33K+ monthly searches). Good balance of price and service quality for patients who want flexibility.
$229–$299/month
Higher price includes comprehensive metabolic bloodwork at intake and full-service clinical support. Good choice if you value the included lab work.
Affiliate disclosure: GLP1CompareHub earns a commission if you enroll. See disclosure.
FAQ
How much does compounded tirzepatide cost per month?
Compounded tirzepatide ranges from approximately $167–$299/month depending on the provider and plan structure. TMates offers the lowest price at ~$167/month on a 12-month commitment plan. Monthly plans and providers with more clinical services range from $229–$299/month. All prices are without insurance — compounded tirzepatide is not covered by insurance.
Why is compounded tirzepatide cheaper than Zepbound?
Branded Zepbound (Eli Lilly) costs approximately $1,086–$1,300/month at retail without insurance. Compounded tirzepatide uses the same active pharmaceutical ingredient (tirzepatide) but is prepared by 503A compounding pharmacies without the branded packaging, delivery system, or drug company pricing. Compounded preparations are legal under federal pharmacy regulations and must be prescribed by a licensed physician.
Is the cheapest compounded tirzepatide the best option?
Not necessarily. Lower prices often reflect commitment plans (12-month upfront) or less clinical support. Consider: the provider's consultation and monitoring quality, whether follow-up visits are included, how they handle dose adjustments, and their 503A pharmacy partnerships. The cheapest option per month may cost more overall if you need additional consultations.
Are there hidden fees with compounded tirzepatide providers?
Some providers charge separately for consultations, lab work, or follow-up visits. Others include these in the monthly price. Always ask before enrolling: (1) Is the initial consultation included? (2) Are follow-up visits included? (3) What happens if I need a dose adjustment? (4) Is lab work required and who pays for it? (5) What is the cancellation policy?
What is the FDA status of compounded tirzepatide in 2026?
As of early 2026, compounded tirzepatide from 503A pharmacies (patient-specific, individually compounded) remains legal for licensed pharmacies preparing individually prescribed formulations. The FDA resolved the Zepbound/Mounjaro drug shortage in March 2025 and has taken enforcement actions against bulk 503B manufacturing. 503A compounding (patient-specific, small batch) has continued under physician prescription. Regulatory status can change — verify current compliance with your provider.
Related Pages
How this page is reviewed
Editorially reviewed by GLP1CompareHub Editorial Team. We are an independent affiliate publisher — we are not licensed medical providers and this site does not deliver medical advice. Every claim on this page is sourced to a verifiable origin (peer-reviewed study, FDA documentation, live brand-site crawl, or our Katalys partner dashboard).
Affiliate disclosure: We earn a commission when you sign up with a provider through our links — at no extra cost to you. We do not rank providers by what they pay us; we rank by patient fit. Full disclosure. Read our methodology · medical disclaimer.